Forte Biosciences, Inc. (FBRX)

Forte Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	16.36	37.13	41.1	42.04	58.77	6.94
Cash & Short-Term Investments	16.36	37.13	41.1	42.04	58.77	6.94
Cash Growth	-64.57%	-9.67%	-2.25%	-28.45%	746.88%	38.35%
Prepaid Expenses	1.03	1.04	0.34	0.39	0.96	0.54
Other Current Assets	0.27	0.17	0.07	0.09	0.18	0.02
Total Current Assets	17.67	38.33	41.51	42.52	59.9	7.51
Property, Plant & Equipment	0.09	0.11	-	-	0.1	0.15
Long-Term Deferred Charges	-	-	-	0.11	0.29	-
Other Long-Term Assets	0.19	0.54	0.49	0.68	0.96	-
Total Assets	17.95	38.98	42	43.31	61.24	7.66
Accounts Payable	5.16	1.42	1.15	0.95	1.24	1.57
Accrued Expenses	3.42	2.24	2.03	0.81	1.02	0.34
Total Current Liabilities	8.58	3.67	3.18	1.76	2.26	1.91
Total Liabilities	8.58	3.67	3.18	1.76	2.26	1.91
Common Stock	0	0.04	0.02	0.02	0.01	0
Additional Paid-In Capital	156.21	153.79	125.84	114.7	110.42	0.2
Retained Earnings	-146.84	-118.52	-87.04	-73.17	-51.46	-4.97
Comprehensive Income & Other	0	0	-	-	-	-
Total Common Equity	9.37	35.31	38.82	41.55	58.98	-4.77
Shareholders' Equity	9.37	35.31	38.82	41.55	58.98	5.75
Total Liabilities & Equity	17.95	38.98	42	43.31	61.24	7.66
Net Cash (Debt)	16.36	37.13	41.1	42.04	58.77	6.94
Net Cash Growth	-64.57%	-9.67%	-2.25%	-28.45%	746.88%	38.35%
Net Cash Per Share	8.86	29.40	59.11	75.25	199.64	82.28
Filing Date Shares Outstanding	1.46	1.46	0.84	0.59	0.54	0.4
Total Common Shares Outstanding	1.46	1.45	0.84	0.59	0.51	0.4
Working Capital	9.09	34.66	38.33	40.76	57.64	5.59
Book Value Per Share	6.42	24.30	46.21	70.40	114.92	-11.92
Tangible Book Value	9.37	35.31	38.82	41.55	58.98	-4.77
Tangible Book Value Per Share	6.42	24.30	46.21	70.40	114.92	-11.92
Machinery	0.12	0.12	-	-	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.